CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Gustav A. Christensen, President and Chief Executive Officer of Dyax, will present at the Cowen and Company 30th Annual Health Care Conference, being held March 8-11th at the Marriott Copley Place in Boston, MA. Mr. Christensen will present a corporate progress report, including an update on the Company’s commercial activities for KALBITOR® (ecallantide) and clinical development programs. The Dyax presentation is scheduled for Wednesday, March 10th at 8:45 AM (ET).
